Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial ...

“In regards to specific diseases, there are two animal studies showing that CBG may be beneficial in inflammatory bowel ...

He's worth about $1 billion. So what exactly is Vivek Ramaswamy’s business background and how did he get rich so young? A ...

It's very common for friendships to shift after one friend has had a baby because the new [parent] has entered into a new ...

New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...

You've completed your fast, but your stomach isn't feeling quite right. Bloating, acid reflux, or sudden cramps—sound ...

Developed by Johnson & Johnson, guselkumab (GUS) is the first approved fully-human, dual-acting IL-23p19 subunit inhibitor that blocks IL-23 and binds to CD64, a receptor on cells that produce IL-23.